Ind-Swift Limited Stock

Equities

524652

INE788B01028

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:47 2024-04-30 am EDT 5-day change 1st Jan Change
25.45 INR -1.96% Intraday chart for Ind-Swift Limited +24.63% +42.34%
Sales 2022 4.02B 48.14M Sales 2023 4.11B 49.24M Capitalization 391M 4.69M
Net income 2022 -200M -2.4M Net income 2023 260M 3.12M EV / Sales 2022 2.69 x
Net Debt 2022 10.2B 122M Net Debt 2023 9.8B 117M EV / Sales 2023 2.48 x
P/E ratio 2022
-3.02 x
P/E ratio 2023
1.5 x
Employees 1,200
Yield 2022 *
-
Yield 2023
-
Free-Float 33.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.96%
1 week+24.63%
Current month+39.07%
1 month+39.07%
3 months+40.61%
6 months+68.43%
Current year+42.34%
More quotes
1 week
21.44
Extreme 21.44
25.96
1 month
18.15
Extreme 18.15
31.09
Current year
15.19
Extreme 15.19
31.09
1 year
7.75
Extreme 7.75
31.09
3 years
3.92
Extreme 3.92
31.09
5 years
1.86
Extreme 1.86
31.09
10 years
1.86
Extreme 1.86
31.09
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 86-12-10
Director of Finance/CFO - -
Compliance Officer - 22-05-29
Members of the board TitleAgeSince
Chairman 67 86-06-05
Director/Board Member 41 03-08-30
Director/Board Member 72 86-12-10
More insiders
Date Price Change Volume
24-04-30 25.45 -1.96% 998
24-04-29 25.96 +4.97% 49,070
24-04-26 24.73 +4.97% 41,183
24-04-25 23.56 +4.85% 36,590
24-04-24 22.47 +4.80% 46,076

Delayed Quote Bombay S.E., April 30, 2024 at 06:00 am EDT

More quotes
Ind Swift Limited is an India-based pharmaceutical manufacturing and marketing company. The Company operates in both domestic and export markets. It is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The Company is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. It operates through various divisions, such as Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte. The Company also provides a range of COVID19 products, including masks, travel kits, hand sanitizers, and gloves. It has also launched two products, Stevia (natural sweetener) and Hangover (helps avoid alcoholic hangover). The Company also has five plants in India.
More about the company
  1. Stock Market
  2. Equities
  3. 524652 Stock